Section 216 of the Protecting Access to Medicare Act of 2014 changed the way that rates are established on the Medicare Clinical Laboratory Fee Schedule. Laboratories must report information to CMS about their private payor rates and volumes every three years. Starting in 2020, hospital outreach laboratories serving non-hospital patients must do so as well, or face the prospect of civil monetary penalties for failure to report. This one-hour webinar will help hospitals understand their reporting obligations under PAMA Sec. 216.
Curtis A. Hanson, M.D., Chief Medical Officer, Mayo Clinic Laboratories
Dr. Hanson is the Chief Medical Officer at Mayo Clinic Laboratories and a member of ACLA’s Board of Directors. With 30 years of clinical laboratory testing experience, pathology expertise, and insight into laboratory operational concerns, Dr. Hanson has been a practicing hematopathologist at Mayo Clinic since 1993.
Julie Khani, President, ACLA
Julie Khani is the president of the American Clinical Laboratory Association (ACLA), the largest organization representing the public policy interests of laboratories. Khani leads ACLA’s efforts to advance public policies that promote innovation and protect and enhance patient access to life-improving and life-saving diagnostics.
Joyce Gresko, J.D., Legal Counsel, ACLA
Joyce Gresko is an attorney in Alston & Bird’s Washington, D.C., office, where she is a member of the Health Care and Legislative & Public Policy Teams. She focuses her practice on health care regulatory, legislative and compliance matters. She assists clients on a daily basis to understand and resolve issues She assists clients on a daily basis to understand and resolve issues relating to Medicare and Medicaid payment and coding, federal and state fraud and abuse laws, effective compliance programs and health care quality.
PDF download available here: